Cargando…
Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study
INTRODUCTION: Research on associations between medication use during pregnancy and congenital anomalies is significative for assessing the safe use of a medicine in pregnancy. Congenital anomaly (CA) registries do not have optimal information on medicine exposure, in contrast to prescription databas...
Autores principales: | de Jonge, Linda, Garne, Ester, Gini, Rosa, Jordan, Susan E., Klungsoyr, Kari, Loane, Maria, Neville, Amanda J., Pierini, Anna, Puccini, Aurora, Thayer, Daniel S., Tucker, David, Vinkel Hansen, Anne, Bakker, Marian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608981/ https://www.ncbi.nlm.nih.gov/pubmed/26153398 http://dx.doi.org/10.1007/s40264-015-0321-9 |
Ejemplares similares
-
EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016) -
Anti-asthmatic prescriptions in children with and without congenital anomalies: a European data linkage study.
por: Divin, Natalie, et al.
Publicado: (2022) -
Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study
por: Given, Joanne E, et al.
Publicado: (2018) -
Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study
por: Garne, E, et al.
Publicado: (2016) -
Asthma medication prescribing before, during and after pregnancy: a study in seven European regions
por: Charlton, Rachel A, et al.
Publicado: (2016)